BACKGROUND: Sapovirus is increasingly recognized as an important cause of acute gastroenteritis (AGE) in children. We identified risk factors and characterized the clinical profile of sapovirus AGE in a birth cohort in León, Nicaragua. METHODS: We conducted a case-control study nested within a birth cohort (n = 444). Fieldworkers conducted weekly household AGE surveillance. AGE stools were tested for sapovirus by reverse transcriptase quantitative polymerase chain reaction. For each first sapovirus episode, we selected 2 healthy age-matched controls and estimated independent risk factors of sapovirus AGE using conditional logistic regression. We compared clinical characteristics of sapovirus AGE episodes with episodes associated with other etiologies and identified co-infections with other enteric pathogens. RESULTS: From June 2017 to July 2019, we identified 63 first sapovirus AGE episodes and selected 126 controls. Having contact with an individual with AGE symptoms and vaginal delivery were independent risk factors for sapovirus AGE. All cases experienced diarrhea, lasting a median 6 days; 23% experienced vomiting. Compared with children with AGE due to another etiology, sapovirus AGE was similar in severity, with less reported fever. Most cases experienced co-infections and were more likely than controls to be infected with diarrheagenic Escherichia coli or astrovirus. CONCLUSIONS: Sapovirus was a commonly identified AGE etiology in this Central American setting, and symptoms were similar to AGE associated with other etiologies. The association between vaginal delivery and sapovirus is a novel finding. Gut microbiome composition might mediate this relationship, or vaginal delivery might be a proxy for other risk factors. Further investigation into more specific biological mechanisms is warranted.
BACKGROUND: Sapovirus is increasingly recognized as an important cause of acute gastroenteritis (AGE) in children. We identified risk factors and characterized the clinical profile of sapovirus AGE in a birth cohort in León, Nicaragua. METHODS: We conducted a case-control study nested within a birth cohort (n = 444). Fieldworkers conducted weekly household AGE surveillance. AGE stools were tested for sapovirus by reverse transcriptase quantitative polymerase chain reaction. For each first sapovirus episode, we selected 2 healthy age-matched controls and estimated independent risk factors of sapovirus AGE using conditional logistic regression. We compared clinical characteristics of sapovirus AGE episodes with episodes associated with other etiologies and identified co-infections with other enteric pathogens. RESULTS: From June 2017 to July 2019, we identified 63 first sapovirus AGE episodes and selected 126 controls. Having contact with an individual with AGE symptoms and vaginal delivery were independent risk factors for sapovirus AGE. All cases experienced diarrhea, lasting a median 6 days; 23% experienced vomiting. Compared with children with AGE due to another etiology, sapovirus AGE was similar in severity, with less reported fever. Most cases experienced co-infections and were more likely than controls to be infected with diarrheagenic Escherichia coli or astrovirus. CONCLUSIONS: Sapovirus was a commonly identified AGE etiology in this Central American setting, and symptoms were similar to AGE associated with other etiologies. The association between vaginal delivery and sapovirus is a novel finding. Gut microbiome composition might mediate this relationship, or vaginal delivery might be a proxy for other risk factors. Further investigation into more specific biological mechanisms is warranted.
Authors: Nancy P Nenonen; Charles Hannoun; Lennart Svensson; Kjell Torén; Lars-Magnus Andersson; Johan Westin; Tomas Bergström Journal: J Clin Microbiol Date: 2014-04-23 Impact factor: 5.948
Authors: Leyi Wang; Douglas Marthaler; Richard Fredrickson; Phillip C Gauger; Jianqiang Zhang; Eric R Burrough; Thomas Petznick; Ganwu Li Journal: Transbound Emerg Dis Date: 2019-09-13 Impact factor: 5.005
Authors: Sylvia Becker-Dreps; Filemon Bucardo; Samuel Vilchez; Luis Enrique Zambrana; Lan Liu; David J Weber; Rodolfo Peña; Leslie Barclay; Jan Vinjé; Michael G Hudgens; Johan Nordgren; Lennart Svensson; Douglas R Morgan; Félix Espinoza; Margarita Paniagua Journal: Pediatr Infect Dis J Date: 2014-11 Impact factor: 2.129
Authors: Shaohua Lei; Erica L Twitchell; Ashwin K Ramesh; Tammy Bui; Elizabeth Majette; Christine M Tin; Roger Avery; Gustavo Arango-Argoty; Liqing Zhang; Sylvia Becker-Dreps; M Andrea Azcarate-Peril; Xi Jiang; Lijuan Yuan Journal: J Gen Virol Date: 2019-11 Impact factor: 3.891
Authors: Cian J Hill; Denise B Lynch; Kiera Murphy; Marynka Ulaszewska; Ian B Jeffery; Carol Anne O'Shea; Claire Watkins; Eugene Dempsey; Fulvio Mattivi; Kieran Tuohy; R Paul Ross; C Anthony Ryan; Paul W O' Toole; Catherine Stanton Journal: Microbiome Date: 2017-01-17 Impact factor: 14.650
Authors: Jennifer L Cannon; Matthew H Seabolt; Ruijie Xu; Anna Montmayeur; Soo Hwan Suh; Marta Diez-Valcarce; Filemón Bucardo; Sylvia Becker-Dreps; Jan Vinjé Journal: Viruses Date: 2022-06-27 Impact factor: 5.818
Authors: Paul D Brewer-Jensen; Yaoska Reyes; Sylvia Becker-Dreps; Fredman González; Michael L Mallory; Lester Gutiérrez; Omar Zepeda; Edwing Centeno; Nadja Vielot; Marta Diez-Valcarce; Jan Vinjé; Ralph Baric; Lisa C Lindesmith; Filemon Bucardo Journal: Viruses Date: 2022-09-16 Impact factor: 5.818
Authors: Yaoska Reyes; Fredman González; Lester Gutiérrez; Patricia Blandón; Edwing Centeno; Omar Zepeda; Christian Toval-Ruíz; Lisa C Lindesmith; Ralph S Baric; Nadja Vielot; Marta Diez-Valcarce; Jan Vinjé; Lennart Svensson; Sylvia Becker-Dreps; Johan Nordgren; Filemón Bucardo Journal: J Infect Dis Date: 2022-01-05 Impact factor: 7.759
Authors: Mark R Zweigart; Sylvia Becker-Dreps; Filemón Bucardo; Fredman González; Ralph S Baric; Lisa C Lindesmith Journal: Viruses Date: 2021-10-09 Impact factor: 5.048